Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00428142
What this trial is testing

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 95
Not applicableStudy completedNCT04068883
What this trial is testing

Controlled DTI Evaluations in High School Football and Female Soccer to Evaluate Efficacy of Jugular Compression Collar

Who this might be right for
MTBI - Mild Traumatic Brain InjuryConcussion, Mild
Children's Hospital Medical Center, Cincinnati 488
Large-scale testing (Phase 3)Study completedNCT01594762
What this trial is testing

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Infection
Dipexium Pharmaceuticals, Inc. 200
Not applicableEnded earlyNCT06453941
What this trial is testing

Yizhi Baduanjin for Patients With Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment (MCI)
The University of Hong Kong 1
Not applicableNot Yet RecruitingNCT07473479
What this trial is testing

Effect of Virtual Reality Distraction on Perceived Pain During Dental Hygiene in Children With Mild Intellectual Disability: A Randomized Controlled Trial

Who this might be right for
Mild Intellectual Disability
Oasi Research Institute-IRCCS 102
Not applicableNot Yet RecruitingNCT07456462
What this trial is testing

Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance

Who this might be right for
Alzheimer Dementia (AD)Mild Cognitive Impairment (MCI)
IRCCS San Raffaele 50
Early research (Phase 1)Ended earlyNCT04803227
What this trial is testing

Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19

Who this might be right for
Covid19
Histogen 13
Early research (Phase 1)Study completedNCT00005580
What this trial is testing

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Virginia Commonwealth University 54
Not applicableEnded earlyNCT05059080
What this trial is testing

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

Who this might be right for
COVID-19Long COVID
Hoffmann-La Roche 72
Testing effectiveness (Phase 2)Study completedNCT00438880
What this trial is testing

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00151827
What this trial is testing

Olmesartan Medoxomil in Hypertension and Renal Impairment

Who this might be right for
Essential HypertensionRenal Impairment
Sankyo Pharma Gmbh 393
Not applicableStudy completedNCT04512027
What this trial is testing

Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.

Who this might be right for
COVID-19
Composite Interceptive Med Science 10
Not applicableLooking for participantsNCT06783283
What this trial is testing

TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)

Who this might be right for
Mild Cognitive Impairment (MCI)
Centre for Addiction and Mental Health 20
Early research (Phase 1)Looking for participantsNCT07540754
What this trial is testing

Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function

Who this might be right for
Diabetes MellitusWeight Loss
Fujian Shengdi Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT04079803
What this trial is testing

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 64
Early research (Phase 1)Study completedNCT01579461
What this trial is testing

Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects

Who this might be right for
PharmacokineticsHealthy SubjectsMild and Moderate Hepatic Impairment
Astellas Pharma Europe B.V. 32
Large-scale testing (Phase 3)Study completedNCT00987246
What this trial is testing

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Who this might be right for
Actinic Keratosis
Almirall, S.A. 470
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Not applicableLooking for participantsNCT07638748
What this trial is testing

Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentSubjective Cognitive Decline (SCD)
The University of Texas Health Science Center, Houston 10
Next Page